Riskpilot← Back to searchSign inGet full accessSTUDIUM ACTORIS AS
ASActiveOrg 913885155Dokka 1C, 1671 KråkerøyActivities of performing arts · NACE 9020Est. 20143 employees
Revenue 2024
NOK 2,7M
-17% vs 2023
EBITDA margin
3.0%
-14% vs 2023
Equity ratio
12.2%
Financial strength
Net profit 2024
NOK -6K
+4% vs 2023
| Revenue | NOK 2,7M | -17% |
| EBITDA | NOK 83K | -14% |
| Net profit | NOK -6K | +4% |
| Total assets | NOK 664K | +19% |
| Equity | NOK 81K | -7% |
| Employees | 3 | — |
Legal name
STUDIUM ACTORIS AS
Org number
913885155
Legal form
Aksjeselskap
NACE code
9020 · Activities of performing arts
Founded
14. juli 2014
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av frittstående teatergruppe og alt som hører naturlig til dette. Selskapet skal bare drive med teaterutvikling og forestillinger. Selskapet har ingen gevinstformål, men vil tilbakeføre eventuelle gevinster til teatervirksomheten.
Address
Dokka 1C, 1671 Kråkerøy
Phone
+4797485565
Email
office@studiumactoris.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 438 | 3 712 | 4 283 | 3 312 | 2 734 |
| Staff expenses | −1 011 | −1 406 | −1 644 | −1 165 | −1 162 |
| EBITDA | 21 | 60 | 43 | 97 | 83 |
| Depreciation & amort. | −8 | −22 | −26 | −68 | −70 |
| EBIT | 12 | 38 | 17 | 29 | 13 |
| Net financials | 0 | −6 | −16 | −29 | −13 |
| Profit before tax | 12 | 32 | 1 | 0 | 0 |
| Tax | −0 | −0 | 1 | 6 | 6 |
| Net profit | 12 | 32 | 0 | −6 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 755 | 1 277 | 506 | 556 | 664 |
| Equity | 60 | 92 | 93 | 87 | 81 |
| Long-term debt | 0 | 0 | 0 | 202 | 160 |
| Short-term debt | 695 | 1 184 | 414 | 268 | 423 |
| Total debt | 695 | 1 184 | 414 | 470 | 583 |
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
20202024
Equity ratio
12.2%
This company
38.2%
Market median
-68% vs market
20202024
Return on equity
-7.0%
This company
18.4%
Market median
-138% vs market
20202024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20202024
Asset turnover
4.12×
This company
1.12×
Market median
+268% vs market
20202024
Debt / equity
7.19×
This company
0.62×
Market median
-1060% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Former (1) | ||
| Board of Directors | 2019 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
STUDIUM ACTORIS AS 
KULTURFANGST ASBoard members of STUDIUM ACTORIS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jannicke Stensnes | Board of Directors | 0 companies |
| Egil Freddy Syversen | Board of Directors | 0 companies |
| Paolo Martini | Chairman | 0 companies |
| Hans Jørgen Ramberg | Board of Directors | 0 companies |